patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat170	NRAS p.Q61L (Missense)	NRAS	Selumetinib	152	1671	76	652	27.454	88.106	141.237	76.712	184.463	366.615	0.0	31515.0
MEL-IPI_Pat170	NRAS p.Q61L (Missense)	NRAS Somatic Variant	Selumetinib	102	1721	54	674	16.818	64.816	128.408	76.712	183.184	361.712	1.926e-06	25278.0
MEL-IPI_Pat170	NRAS p.Q61L (Missense)	NRAS Somatic Variant Missense	Selumetinib	100	1723	53	675	16.602	60.604	125.814	76.81	183.34	361.466	7.004e-07	25202.0
MEL-IPI_Pat170	NRAS p.Q61L (Missense)	NRAS Somatic Variant Missense p.Q61L	Selumetinib	15	1808	8	720	9.108	58.588	122.967	71.056	175.691	352.643	0.026	4197.0
MEL-IPI_Pat170	RAD51B p.D186N (Missense)	RAD51B	Olaparib	134	1689	72	690	73.222	173.48	289.595	77.594	162.646	326.025	0.967	24913.5
MEL-IPI_Pat170	RAD51B p.D186N (Missense)	RAD51B Somatic Variant	Olaparib	21	1802	11	751	106.14	155.728	171.049	74.761	163.786	324.354	0.486	3625.0
MEL-IPI_Pat170	RAD51B p.D186N (Missense)	RAD51B Somatic Variant Missense	Olaparib	19	1804	9	753	79.482	110.372	120.45	75.198	164.307	324.233	0.985	3401.0
MEL-IPI_Pat170	RAD51B p.D186N (Missense)	RAD51B Somatic Variant Missense p.D186N	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
